Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
Pau Celada, Analı́a Bortolozzi, Francesc Artigas
CNS Drugs (2013) Vol. 27, Iss. 9, pp. 703-716
Closed Access | Times Cited: 293

Showing 1-25 of 293 citing articles:

Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 597
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 585
Structure and function of serotonin G protein-coupled receptors
John D. McCorvy, Bryan L. Roth
Pharmacology & Therapeutics (2015) Vol. 150, pp. 129-142
Open Access | Times Cited: 312
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 304
A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan, Justine Kent, Seth C. Hopkins, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 16, pp. 1497-1506
Open Access | Times Cited: 245
P5-HT1A receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function
Álvaro L. Garcia‐García, Adrian Newman‐Tancredi, E. David Leonardo
Psychopharmacology (2013) Vol. 231, Iss. 4, pp. 623-636
Open Access | Times Cited: 215
The Roles of Serotonin in Neuropsychiatric Disorders
Mahsa Pourhamzeh, Fahimeh Ghasemi Moravej, Mehrnoosh Arabi, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 6, pp. 1671-1692
Closed Access | Times Cited: 212
Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies
Sudhakar Selvaraj, Danilo Arnone, Alessandra Cappai, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 45, pp. 233-245
Closed Access | Times Cited: 190
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2Receptor Mechanism of Action
Nina Dedic, Philip Jones, Seth C. Hopkins, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 1, pp. 1-14
Open Access | Times Cited: 151
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
Domenico De Berardis, Michele Fornaro, Alessandro Valchera, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2888-2888
Open Access | Times Cited: 159
Serotonin receptors in depression and anxiety: Insights from animal studies
Elżbieta Żmudzka, Kinga Sałaciak, Jacek Sapa, et al.
Life Sciences (2018) Vol. 210, pp. 106-124
Closed Access | Times Cited: 153
Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications
Philippe De Deurwaerdère, Giuseppe Di Giovanni
Progress in Neurobiology (2016) Vol. 151, pp. 175-236
Closed Access | Times Cited: 151
Anxiety in Patients with Schizophrenia: Epidemiology and Management
Henk Temmingh, Dan J. Stein
CNS Drugs (2015) Vol. 29, Iss. 10, pp. 819-832
Closed Access | Times Cited: 149
The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
Stephan Köhler, Katharina Cierpinsky, Golo Kronenberg, et al.
Journal of Psychopharmacology (2015) Vol. 30, Iss. 1, pp. 13-22
Closed Access | Times Cited: 128
Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
Tomas Hökfelt, Swapnali Barde, Qing Xu, et al.
Frontiers in Neural Circuits (2018) Vol. 12
Open Access | Times Cited: 124
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
Thomas Pokorny, Katrin H. Preller, Rainer Kraehenmann, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 4, pp. 756-766
Closed Access | Times Cited: 117
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
Dasiel O. Borroto‐Escuela, Jens Carlsson, Patricia Ambrogini, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 116
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
David Baumeister, Georgina L. Barnes, Giovanni Giaroli, et al.
Therapeutic Advances in Psychopharmacology (2014) Vol. 4, Iss. 4, pp. 156-169
Open Access | Times Cited: 113
GPCRs: Lipid-Dependent Membrane Receptors That Act as Drug Targets
Amitabha Chattopadhyay
Advances in Biology (2014) Vol. 2014, pp. 1-12
Open Access | Times Cited: 97
Classics in Chemical Neuroscience: Aripiprazole
Austen B. Casey, Clinton E. Canal
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1135-1146
Open Access | Times Cited: 96
Vortioxetine (brintellix): a new serotonergic antidepressant.
Andrew D'Agostino, Clayton English, Jose A Rey
PubMed (2015) Vol. 40, Iss. 1, pp. 36-40
Closed Access | Times Cited: 95
The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects
Dasiel O. Borroto‐Escuela, Patrizia Ambrogini, Barbara Chruścicka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1927-1927
Open Access | Times Cited: 80
Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression
Darakhshan Jabeen Haleem
Current Neuropharmacology (2019) Vol. 17, Iss. 12, pp. 1098-1108
Open Access | Times Cited: 76
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 64
Perspectives for therapy of treatment‐resistant depression
Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Świȩcicki, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 17, pp. 4181-4200
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top